ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (Q57642222)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing |
article |
Statements
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (English)
ACMG Board of Directors
13 November 2014
1 reference